Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Karthik H. Chandrasekharan"'
Autor:
Wen-Rui Ma, Karthik H. Chandrasekharan, Chang-Sheng Nai, Yong-Xiang Zhu, Javaid Iqbal, Shang Chang, You-Wei Cheng, Xin-Yu Wang, Christos V. Bourantas, Yao-Jun Zhang
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundPercutaneous coronary intervention (PCI) has a well-established role in revascularization for coronary artery disease. We performed network meta-analysis to provide evidence on optimal intervention strategies for de novo lesions in small co
Externí odkaz:
https://doaj.org/article/b5a5687b3b324fda84f491a20bb39e3e
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Externí odkaz:
https://doaj.org/article/a6b5bb6ffeba4cbd884c314c8ef6d2e4
Autor:
Retesh Bajaj, Jeroen Eggermont, Stephanie J. Grainger, Lorenz Räber, Ramya Parasa, Ameer Hamid A. Khan, Christos Costa, Emrah Erdogan, Michael J. Hendricks, Karthik H. Chandrasekharan, Mervyn Andiapen, Patrick W. Serruys, Ryo Torii, Anthony Mathur, Andreas Baumbach, Jouke Dijkstra, Christos V. Bourantas
Publikováno v:
Atherosclerosis, 345, 15-25. ELSEVIER IRELAND LTD
BACKGROUND AND AIMS Accurate classification of plaque composition is essential for treatment planning. Intravascular ultrasound (IVUS) has limited efficacy in assessing tissue types, while near-infrared spectroscopy (NIRS) provides complementary info
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a017f334842137e61ce3011a4cffd8d
https://hdl.handle.net/1887/3567653
https://hdl.handle.net/1887/3567653
Publikováno v:
EuroIntervention. 17:532-533
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b53a4c35bbabb191b34d855455cc4d5
https://doi.org/10.4244/eijv17i7a95
https://doi.org/10.4244/eijv17i7a95
Autor:
Karthik H Chandrasekharan, Samantha C. Salvage, Antony P. Jackson, Angela F. Dulhunty, Christopher L.-H. Huang, Kamalan Jeevaratnam, Andrew J. Thompson
Publikováno v:
British Journal of Pharmacology. 175:1260-1278
S.C.S. and A.P.J. are funded by the British Heart Foundation (PG/14/79/31102). K.J. is funded by the Fundamental Research Grant Scheme (FRGS/2/2014/SKK01/PERDANA/ 02/1), Ministry of Education, Malaysia and the Research Support Fund, Faculty of Health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69ace7f3f3470a901e88be4fd8182382
https://doi.org/10.1111/bph.13807
https://doi.org/10.1111/bph.13807
Autor:
Samantha C, Salvage, Karthik H, Chandrasekharan, Kamalan, Jeevaratnam, Angela F, Dulhunty, Andrew J, Thompson, Antony P, Jackson, Christopher L-H, Huang
Publikováno v:
British journal of pharmacology. 175(8)
Flecainide suppresses cardiac tachyarrhythmias including paroxysmal atrial fibrillation, supraventricular tachycardia and arrhythmic long QT syndromes (LQTS), as well as the Ca(2+)‐mediated, catecholaminergic polymorphic ventricular tachycardia (CP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9481a5c7c5b8eaf9b046aac52f77a212
https://pubmed.ncbi.nlm.nih.gov/28369767
https://pubmed.ncbi.nlm.nih.gov/28369767